Bioinformatics Market Revenue to Hit USD 34,749.78 million by 2028

Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline involving computer technology to collect, store, analyze, and disseminate biological data and information, such as DNA and amino acid sequences or observations about those sequences. Bioinformatics is essential for the management of data in modern biology and medicine. Scientists and clinicians use databases that organize and guide biological information to increase the understanding of health and disease and, in certain cases, as part of medical care.

Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00003993/?utm_source=OpenPR&utm_medium=10357

Leading Companies:

Dassault Systèmes
Bruker Corporation
Agilent Technologies, Inc.
Eurofins Scientific
Illumina, Inc.
PerkinElmer Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Biomax Informatics AG
Genebio

The bioinformatics market witnessed a positive impact due to increased demand for COVID-19 detection kits during the pandemic. At the biological level, SARS-CoV-2 and COVID-19 research involves high-throughput technologies, such as next-generation sequencing for detecting the genome of SARS-CoV-2, databases storing SARS-CoV-2 genomes and variants, and bioinformatics software tools and databases for analyzing and storing host-virus interactions. At the medical level, the search for therapeutic strategies, the identification of COVID-19 biomarkers, the discovery of therapeutic targets for drugs, and the bioinformatics approaches for drug repurposing, i.e., the use of already available drugs for the COVID-19 disease, were the main research themes, which further escalated the market growth. Moreover, there has been an increase in the use of synthetic gene-based technologies for studying SAR-CoV-2 virulence and facilitating vaccine development.

In the field of genetics and genomics, bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a key role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and, more generally, in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals, such as reducing global health inequalities by providing developing countries with efficient, cost-effective, and robust means of preventing, diagnosing, and treating major diseases that burden their populations.

Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00003993/?utm_source=OpenPR&utm_medium=10357

About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.